Overall, CXCR5 CAR-T cells reacted stronger towards primary FL, CLL, and MCL samples with respect to IFNγ secretion compared to CD19 CAR-T cells (Fig. 3a–c). The gene discussed is CXCR5; the disease is B-cell chronic lymphocytic leukemia.